Activation of quiescent ABL-transduced hemopoietic stem cells

Oncogene

Volumn 13, Issue 11, 1996, Pages 2397-2405

  Chung, Siu Wah ^a   Chen, Hong ^a   Wong, Peter M C ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABL; Hematopoietic stem cells

Indexed keywords

FLUOROURACIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CELL CLONE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EMBRYO; EXPRESSION VECTOR; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; FLUOROURACIL; GENES, ABL; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED BALB C; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; TRANSFECTION; VIRUS INTEGRATION;

EID: 0030444207     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ and Jones RJ. (1993). BCR-ABL gene rearrangement and expression of primitive hemopoietic progenitors in chronic myeloid leukemia. Blood, 81, 2898.
2. Brecher G, Bookstein N, Redfearn W, Necas E, Pallavicini MG and Cronkite EP. (1993). Self-renewal of the long-term repopulating stem cell. Proc. Natl. Acad. Sci. USA, 90, 6028.
3. Bretcher G, Neben S, Yee M, Bullis J and Cronkite EP. (1988). Pluripotential stem cells with normal or reduced self renewal survive lethal irradiation. Exp. Hemat., 16, 627.
4. Chung SW, Cai YL, Nyein R, Brizzolara E, de Kiel K and Wong PMC. (1994). Endogenous growth factor patterns modulate hemopoietic lineage development. Oncogene, 9: 3527.
5. Chung SW, Wong PMC, Shen-Ong G, Ruscetti S, Ishizaka T and Eaves CJ. (1986). Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood, 68, 1074.
6. Chung SW, Ruscetti S and Wong PMC. (1988). Formation of factor-independent hematopoietic multilineage colonies after Abelson virus infection. Blood, 71, 973.
7. Chung SW and Wong PMC. (1995). The biology of abl during hemopoietic stem cell differentiation and development. Oncogene, 10, 1261.
8. Chung SW, Wong PMC, Durkin H, Wu YS and Petersen J. (1991). Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene. Proc. Natl. Acad. Sci. USA, 88, 1585.
9. Cook WD, Groth BF de St, Miller JF, MacDonald HR and Gabathuler R. (1987). Abelson virus transformation of an interleukin 2-dependent antigen specific T-cell line. Mol. Cell. Biol., 7, 2631.
10. Cook WD, Metcalf D, Nicola NA, Burgess AW and Walker F. (1985). Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell, 41, 677.
11. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM and Eaves AC. (1983). Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New Engl. J. Med., 308, 1493.
12. Cronkite EP, Inoue T and Bullis JE. (1987). Bone marrow-cells other than stem cells seed the bone marrow after rescue transfusion of fatally irradiated mice. Exp. Hematol., 16, 627.
13. bcr/abl gene of the Philadelphia chromosome. Science 247, 824.
14. bcr/abl protein. Proc. Natl. Acad. Sci. USA, 85, 9312.
15. bcr/abl protein, unlike v-abl, does not transform NIH3T3 fibroblasts. Science, 237, 532.
16. 1-negative progenitors in treated as well as newly diagnosed patients. Blood, 63, 1172.
17. bcr/abl, the hallmark of chronic myeloid leukemia in man, induces multiple haematopoietic neoplasms in mice. EMBO J., 9, 1069.
18. Elefanty AG and Cory S. (1992). Hematological disease induced in Balb/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Mol. Cell. Biol., 12, 1755.
19. Fialkow PJ, Jacobson RJ, Papayannopoulou T, Penfold GK, Jacobson RT and Hansen JA. (1977). Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, platelet and monocyte/macrophage. Am. J. Med., 63, 125.
20. Fioretos T, Heisterkamp N and Groffen J. (1994). No evidence for genomic imprinting of the human BCR gene. Blood, 83, 3441.
21. Gishizky ML, Johnson-White J and Witte ON. (1993). Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc. Natl. Acad. Sci. USA, 90, 3755.
22. Gishizky ML and Witte ON. (1992). Initiation of deregulated growth of multipotent progenitor cells by bcr/abl in vitro. Science, 256, 836.
23. Hadgson GS and Bradley TR. (1979). Properties of hemopoietic stem cell surviving 5-fluorouracil treatment: evidence for a pre-CFU-s cell? Nature, 281, 381.
24. Han XD, Wong PMC and Chung SW. (1991). Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus infected hemopoietic stem cells. Proc. Natl. Acad. Sci. USA, 88, 10129.
25. Hariharan IK, Adams JM and Cory S. (1988). bcr/abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res., 3, 387.
26. Humphries RK, Abraham S, Krystal G, Landorp P, Lemoine F and Eaves CJ. (1988). Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells. Exp. Hematol., 16, 774.
27. + cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood, 83, 1744.
28. Kelliher MA, McLaughlin J, Witte ON and Rosenberg N. (1990). Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and bcr/abl. Proc. Natl. Acad. Sci. USA, 87, 6649.
29. Kelliher MA, Weckstein DJ, Knott AG, Wortis HH and Rosenberg N. (1993). ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice. Oncogene, 8, 1249.
30. Konopka JB, Watanabe SM and Witte ON. (1984). An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37, 1035.
31. Konopka JB and Witte ON. (1985). Activation of the abl oncogene in murine and human leukemia. Biochimica et Biophysica Acta, 823: 1.
32. bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene, 6, 275.
33. bcl/abl. Blood, 80, 1788.
34. Lerner C and Harrison DE. (1990). 5-fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol., 18, 114.
35. LeBien TW, Hozier J, Minowada J and Kersey JH. (1979). Origin of chronic myelocytic leukemia in a precursor of pre-B lymphocytes. New Engl. J. Med., 301, 144.
36. Mathey-Prevot B, Nabel G, Palacios R and Baltimore D. (1985). Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol. Cell. Biol., 6, 4133.
37. Nowell PC and Hungerford DA. (1960). A minute chromosome in human granulocytic leukemia. Science, 132, 1497.
38. Oliff A, Agranovsky O, McKinney MD, Murty VVVS and Bauchwitz R. (1985). Friends murine leukemia virus-immobilized myeloid cells are converted to tumorigenic cells by Abelson leukemia virus. Proc. Natl. Acad. Sci. USA, 82, 3306.
39. Poirier Y and Jolicoeur P. (1989). Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B and T-cell lymphomas. J. Virol., 63, 2088.
40. Pierce JH, Fiore PPDi, Aaronson SA, Potter M, Pumphrey J, Scott A and Ihle JN. (1985). Neoplastic transformation of mast cells by Abelson-MuLV: Abrogation of IL-3 dependence by a nonautocrine mechanism. Cell, 41, 685.
41. Rovera G, Valtieri M, Mavillo F and Reddy P. (1987). Effect of Abelson murine leukemia virus on granulocyte differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene, 1, 29.
42. Rowley JD. (1973). A new consistent chromosomal abnormality in chronic myelogenous leukemia. Nature, 243, 290.
43. Scott ML, Van Etten RA, Daley GQ and Baltimore D. (1991). v-abl causes a hematopoietic disease distinct from that caused by bcr/abl. Proc. Natl. Acad. Sci. USA, 88, 6505.
44. Sirard C, Laneuville P and Dick JE. (1994). Expression of bcr/abl abrogates factor-dependent growth of human hemopoietic M07E cells by an autocrine mechanism. Blood, 83, 1575.
45. 1-positive chronic granulocytic leukemia. Blood, 56, 1072.
46. v-abl protein tyrosine kinase activity in a primitive, multipotent haemopoietic cell line. Leukemia, 8, 620.
47. Van Zant G. (1984). Studies of hemopoietic stem cells spared by 5-fluorouracil. J. Exp. Med., 159, 679.
48. Verfaillie CM, Miller WJ, Boylan K and McGlave PB. (1992). Selection of benign primitive hematopoietic progenitors in chronic myeloid leukemia on the basis of HLA-DR antigen expression. Blood, 79, 1003.
49. Vogt M, Haggblom C and Swift S. (1987). The induction of growth factor-independence in murine myelocytes by oncogenes results in monoclonal cell lines and is correlated with cell crisis and karyotypic instability. Oncogene Res., 2, 49.
50. Wada C, Shionoya S, Fujino Y, Tokuhiro H, Akahoshi T, Uchida T and Ohtani H. (1994). Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood, 83, 3449.
51. Wong PMC, Chung SW and Nienhuis AW. (1987). Retroviral transfer and expression of the interleukin-3 gene in hemopoietic cells. Genes Dev., 1, 358.
52. Wong PMC, Chung SW, Ruscetti S, Bodine D, Dunbar C and Nienhuis AW. (1989). Retroviral-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells results in a myeloproliferative disorder. Mol. Cell. Biol., 9, 798.
53. Wong PMC, Chung SW, Chui DHK and Eaves CJ. (1986). Unique properties of the first clonogenic hemopoietic precursors to appear in the developing yolk sac. Proc. Natl. Acad. Sci. USA, 83, 851.